M. G. Wulffelé

2.3k total citations · 1 hit paper
11 papers, 1.7k citations indexed

About

M. G. Wulffelé is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, M. G. Wulffelé has authored 11 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in M. G. Wulffelé's work include Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Management and Research (4 papers). M. G. Wulffelé is often cited by papers focused on Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Management and Research (4 papers). M. G. Wulffelé collaborates with scholars based in Netherlands, Belgium and United States. M. G. Wulffelé's co-authors include Coen D.A. Stehouwer, Adriaan Kooy, D. Bets, A. J. M. Donker, J. de Jager, Philippe Lehert, J. van der Kolk, Ron T. Gansevoort, Dick de Zeeuw and J. Verbürg and has published in prestigious journals such as Diabetes Care, Journal of Internal Medicine and British Journal of Clinical Pharmacology.

In The Last Decade

M. G. Wulffelé

10 papers receiving 1.6k citations

Hit Papers

Long term treatment with metformin in patients with type ... 2010 2026 2015 2020 2010 100 200 300 400

Peers

M. G. Wulffelé
Comparison fields: 5 of 113
  • Endocrinology, Diabetes and Metabolism 964
  • Molecular Biology 689
  • Rheumatology 352
  • Surgery 336
  • Physiology 317
Replace D. Bets with:
D. Bets Netherlands
Patrick Sheridan Canada
J. de Jager Netherlands
Gary Ko Hong Kong
R.J. Heine Netherlands
Eric Grossman United States
F Capani Italy
Toshifumi Mannami Japan
Hideki Kishikawa Japan
P W Wilson United States
D. Bets Netherlands View profile →
Citations per field, relative to M. G. Wulffelé
M. G. Wulffelé · 1×
Citations per year, relative to M. G. Wulffelé
M. G. Wulffelé · 1×

Countries citing papers authored by M. G. Wulffelé

Since Specialization
Citations

This map shows the geographic impact of M. G. Wulffelé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. G. Wulffelé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. G. Wulffelé more than expected).

Fields of papers citing papers by M. G. Wulffelé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. G. Wulffelé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. G. Wulffelé. The network helps show where M. G. Wulffelé may publish in the future.

Co-authorship network of co-authors of M. G. Wulffelé

This figure shows the co-authorship network connecting the top 25 collaborators of M. G. Wulffelé. A scholar is included among the top collaborators of M. G. Wulffelé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. G. Wulffelé. M. G. Wulffelé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Work Indexed citations
1 100
2
Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial breakdown →
463
3
Meerwaarde van toevoeging metformine aan insulinetherapie bij type 2-diabetes. Gunstiger gewicht met minder macrovasculaire complicaties
1
4 305
5 22
6 179
7 275
8 188
9 22
10
Discontinuation of metformin in type 2 diabetes patients treated with insulin.
3
11 128

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026